Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:

Vision and mission

Our vision

Immunovia’s vision is to revolutionize blood-based diagnostics and increase survival rates for patients with cancer.

Our mission

To increase survival rates for patients with pancreatic cancer through early detection.


Company values


We push innovation at the forefront to create a new generation of diagnostic tools that give clinicians better opportunity to diagnose cancer – early and with confidence.


Our goal is a world where all patients are properly diagnosed in time for appropriate treatment and better quality of life.


We have an opportunity to lead the way and drive change through breakthrough technology, clinical expertise and new thinking.


We are proud to continue the Swedish tradition of cutting-edge, life science innovation and will continue to display clinical and technical excellence in all things we do.


We are committed to revolutionizing cancer care for better patient management and improved survival.